PROM1 and liver cancer: At present, it is unclear whether CD133 was a de-differentiation marker, which was expressed during the process of oncogenic transformation from mature hepatocytes to poorly differentiated cancer cells or alternatively, CD133-positive HCCs represent a subgroup of liver cancers which were of stem cell origin.